Doxylaminum [INN-Latin] en es it fr

Doxylaminum [INN-Latin] Brand names, Doxylaminum [INN-Latin] Analogs

Doxylaminum [INN-Latin] Brand Names Mixture

  • No information avaliable

Doxylaminum [INN-Latin] Chemical_Formula


Doxylaminum [INN-Latin] RX_link

Doxylaminum [INN-Latin] fda sheet

Doxylaminum [INN-Latin] msds (material safety sheet)

Doxylaminum [INN-Latin] Synthesis Reference

No information avaliable

Doxylaminum [INN-Latin] Molecular Weight

383.228 g/mol

Doxylaminum [INN-Latin] Melting Point

138 oC

Doxylaminum [INN-Latin] H2O Solubility


Doxylaminum [INN-Latin] State


Doxylaminum [INN-Latin] LogP


Doxylaminum [INN-Latin] Dosage Forms

Ophthalmic solution (eye drops)

Doxylaminum [INN-Latin] Indication

For use in the treatment of subacute or chronic angle-closure glaucoma after iridectomy or where surgery is refused or contraindicated.

Doxylaminum [INN-Latin] Pharmacology

Echothiophate Iodide is a potent, long-acting cholinesterase inhibitor used as a miotic in the treatment of glaucoma. Echothiophate iodide will depress both plasma and erythrocyte cholinesterase levels in most patients after a few weeks of eyedrop therapy.

Doxylaminum [INN-Latin] Absorption

No information avaliable

Doxylaminum [INN-Latin] side effects and Toxicity

Side effects include blurred vision or change in near or distant vision and eye pain.

Doxylaminum [INN-Latin] Patient Information

No information avaliable

Doxylaminum [INN-Latin] Organisms Affected

Humans and other mammals